Loading clinical trials...

Esmolol vs. Labetalol in Endoscopic Sinus Surgery | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT03661346

Esmolol vs. Labetalol in Endoscopic Sinus Surgery

The purpose of this study is to compare esmolol and labetalol bleeding and intra-operative visibility scores in functional endoscopic sinus surgery.

Lead sponsor: The University of Texas Medical Branch, Galveston•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps

NCT06036927 · Chronic Sinusitis, Nasal Polyps

COMPLETEDNA

Balloon Sinus Dilation In Office or OR

NCT00939393 · Chronic Sinusitis

UNKNOWN

Endotypic Stability in CRS

NCT06272123 · Chronic Sinusitis

UNKNOWNNA

Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms

NCT06198894 · Chronic Sinusitis

UNKNOWN

Eosinophils Endotypes in Chronic Airway Inflammatory Diseases

NCT04187976 · Eosinophilic Asthma, Chronic Sinusitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 8, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment28

Start dateMar 2017

Last updatedFeb 8, 2021

Condition

Chronic Sinusitis

Locations shown

University of Texas Medical Branch

Galveston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2021Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions